Related references
Note: Only part of the references are listed.Local tirofiban infusion for remnant stenosis in large vessel occlusion: tirofiban ASSIST study
Yong-Won Kim et al.
BMC NEUROLOGY (2020)
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study
Duncan Wilson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Safety of Intra-Arterial Tirofiban Administration in Ischemic Stroke Patients after Unsuccessful Mechanical Thrombectomy
Shuai Zhang et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Catharina J. M. Klijn et al.
EUROPEAN STROKE JOURNAL (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018
J. M. Boulanger et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Rivaroxaban vsWarfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke A Randomized Clinical Trial
Keun-Sik Hong et al.
JAMA NEUROLOGY (2017)
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study
Shoji Arihiro et al.
INTERNATIONAL JOURNAL OF STROKE (2016)
Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial
Yong-Seok Lee et al.
CEREBROVASCULAR DISEASES (2011)
Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial
R Saxena et al.
STROKE (2001)
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study
E Berge et al.
LANCET (2000)
Share Paper
